The University of Texas MD Anderson Cancer Center at SABCS 2026

Dec 8–11, 2026 San Antonio, TX ~11k attendees Website

The University of Texas MD Anderson Cancer Center brings 58 presentations to SABCS 2026 in San Antonio. The Houston cancer center presents work on HER2-positive and triple-negative disease, tumor testing and breast imaging, and its clinicians also moderate, discuss abstracts and sit on panels in several sessions.

OrganizationSABCS 2026 Attendance
Hospitals
Cancer center in Houston and a major institution for breast cancer research and care.
Session
Tue Dec 8
4:30–6:15pm
Session
Wed Dec 9
7–8:30am
Session
Wed Dec 9
noon–1pm
Clinical Case Discussion
Stars at Night 1-2
Poster
Wed Dec 9
12:30–2pm
Pembrolizumab‑Associated Immune‑Related Adverse Events in Breast Cancer: A Systematic Review with Meta‑Analysis
Exhibit Hall
Adverse Effects of Cancer Treatment and Symptom Management
Poster
Wed Dec 9
12:30–2pm
Poster
Wed Dec 9
12:30–2pm
Poster
Wed Dec 9
12:30–2pm
Treatment Patterns and Long-Term Outcomes in pathologic T1a-b Node Negative HER2-Positive Breast Cancer
Exhibit Hall
Breast Cancer: Early Stage - HER2 Positive
Poster
Wed Dec 9
12:30–2pm
Poster
Wed Dec 9
12:30–2pm
A phase II multicenter study of 18F-Fluorthanatrace PET for primary breast cancer
Exhibit Hall
Clinical Biomarkers, Translational Research, and Precision Medicine
Poster
Wed Dec 9
12:30–2pm
Molecular residual disease dynamics and the genomic landscape of male breast cancer in a real-world cohort
Exhibit Hall
Clinical Biomarkers, Translational Research, and Precision Medicine
Poster
Wed Dec 9
12:30–2pm
Poster
Wed Dec 9
12:30–2pm
Poster
Wed Dec 9
12:30–2pm
Changes in ctDNA during neoadjuvant chemotherapy (NAC) as a predictor of residual cancer burden (RCB) in inflammatory breast cancer
Exhibit Hall
Clinical Biomarkers, Translational Research, and Precision Medicine
Poster
Wed Dec 9
12:30–2pm
Poster
Wed Dec 9
12:30–2pm
Poster
Wed Dec 9
12:30–2pm
Ccr7-ccl19/21 expression and functional signaling in inflammatory breast cancer
Exhibit Hall
Patient-Derived and Animal Models of Breast Cancer
Talk
Wed Dec 9
4:38–4:46pm
Part of Rapid Fire 3
A single cell and spatial atlas of preinvasive breast cancer
Stars at Night 1-2
Breast Cancer: Early Stage - Other
Poster
Wed Dec 9
5–6:30pm
Poster
Wed Dec 9
5–6:30pm
Poster
Wed Dec 9
5–6:30pm
Poster
Wed Dec 9
5–6:30pm
Soluble E‑cadherin promotes immune cell-mediated cytotoxicity despite CD95 suppression
Exhibit Hall
Tumor Microenvironment, Immunology, and Angiogenesis
Poster
Wed Dec 9
5–6:30pm
Session
Thu Dec 10
9:30–10:45am
General Session 2
Hall 1
Session
Thu Dec 10
noon–1pm
Molecular Tumor Board
Stars at Night 1-2
Poster
Thu Dec 10
12:30–2pm
Poster
Thu Dec 10
12:30–2pm
Integrating MRI and AI-Derived Digital Pathology for Bimodal Prediction of Triple-Negative Breast Cancer Response to Neoadjuvant Therapy
Exhibit Hall
Artificial Intelligence, Computational Biology, and Systems Biology
Poster
Thu Dec 10
12:30–2pm
Poster
Thu Dec 10
12:30–2pm
Outcomes in De Novo Stage IV triple negative inflammatory breast cancer treated with trimodality therapy
Exhibit Hall
Breast Cancer: Metastatic - Triple Negative
Poster
Thu Dec 10
12:30–2pm
Poster
Thu Dec 10
12:30–2pm
Prospective Identification of Breast Cancer Genetics Evaluation Gaps in the MERIT Mammography Cohort
Exhibit Hall
Breast Cancer Risk, Genetics, and Prevention
Poster
Thu Dec 10
12:30–2pm
Poster
Thu Dec 10
12:30–2pm
Hospital Admissions and Socioeconomic Factors Predict Supportive Care Utilization in Metastatic Breast Cancer
Exhibit Hall
Policy, Access to Care, Health Outcomes and Cancer Care Delivery
Poster
Thu Dec 10
5–6:30pm
Intimate Partner Violence and Overall Survival among Older Women with Breast Cancer
Exhibit Hall
Cancer Survivorship and Quality of Life
Poster
Thu Dec 10
5–6:30pm
Poster
Thu Dec 10
5–6:30pm
Real-world treatment patterns and outcomes in patients with early TNBC using the EVOLVE registry
Exhibit Hall
Breast Cancer: Early Stage - Triple Negative
Poster
Thu Dec 10
5–6:30pm
Reversible Therapy Induced Senescence after AURKA Inhibition in ER⁺ Inflammatory Breast Cancer
Exhibit Hall
Breast Cancer: Metastatic - Hormone Receptor Positive
Poster
Thu Dec 10
5–6:30pm
Poster
Thu Dec 10
5–6:30pm
Pdia4 is a novel mediator of brain metastasis in inflammatory breast cancer
Exhibit Hall
Molecular and Cell Tumor Biology
Session
Fri Dec 11
7–8:30am
Poster Spotlight 12: GLP-1
Hemisfair 3
Talk
Fri Dec 11
8–8:03am
Glp-1 agonist use and contralateral breast cancer risk
Hemisfair 3
Breast Cancer: Early Stage - Other
Talk
Fri Dec 11
8:06–8:09am
Poster
Fri Dec 11
12:30–2pm
Poster
Fri Dec 11
12:30–2pm
Poster
Fri Dec 11
12:30–2pm
Poster
Fri Dec 11
12:30–2pm
Dickkopf-1as a key driver of cancer stemness and a potential therapeutic vulnerability in aggressive breast cancer.
Exhibit Hall
Clinical Biomarkers, Translational Research, and Precision Medicine

Explore the full SABCS 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in San Antonio. Leave your work email and we’ll be in touch.

Privacy

Download the full SABCS 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at The University of Texas MD Anderson Cancer Center

Tell us what you sell and we’ll find the people at The University of Texas MD Anderson Cancer Center most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with the San Antonio Breast Cancer Symposium, UT Health San Antonio or the American Association for Cancer Research. Organization details are derived from SABCS’s published program and exhibitor list. Submit a correction